The FDA’s problem isn’t personnel — it’s enforcement
The resignation of FDA official Marty Makary has sparked media speculation, but the real issue lies in the agency's enforcement of regulations on flavored vapes. The FDA's inconsistent regulatory process has allowed a significant number of unregistered vape products to flood the market, posing risks to consumer safety. To protect youth and maintain legitimacy, the FDA must focus on thorough product reviews and enforce accountability among manufacturers.
- ▪Over 86% of the U.S. vape market consists of unregistered products, undermining the FDA's approval process.
- ▪The FDA's relaxed enforcement has allowed thousands of dangerous and unauthorized vaping products to proliferate in the U.S.
- ▪Only 45 flavored vape products are FDA-approved, while many cheap, unregulated disposables from China remain on the market.
Washington Examiner files mainly under politics. We currently carry 2,236 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | Washington Examiner |
| Canonical URL | https://www.washingtonexaminer.com/op-eds/4584645/fdas-problem-isnt-personnel-its-enforcement/ |
| Publication time | Fri, 29 May 2026 15:00:00 +0000 |
| Retrieval time | 2026-05-29T15:05:01.843Z |
| Last seen | 2026-05-29T15:05:01.843Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | tHkNTxclarjs |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
President Donald Trump’s FDA chief is out, but the reason behind it is not what many think. We must be careful not to learn the wrong lessons from Marty Makary’s resignation. The narrative around the resignation of former Food and Drug Administration official Makary, as reported in the media, implies he was pushed out for refusing to approve fruit-flavored vapes. In reality, the FDA reversed its strict stance against the product last week, and Makary’s departure involved several unrelated factors that marked his tenure, including mass layoffs and policy disputes with lawmakers and Trump. The media’s increased focus on political speculation is irresponsible. It distracts from the real issue at hand: the agency’s failure to implement regulations on the flavored vapes already on the market.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Washington Examiner.
Discussion
0 commentsMore from Washington Examiner
